Lead-in Study of VGB-R04 Gene Therapy for Hemophilia B-- An Observational Survey Analysis Study

Evaluation of the Safety and Efficacy of Hemophilia B Gene Therapy Drug

NCT05203679 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

Lentiviral FIX Gene Therapy

NCT03961243 ·Status: RECRUITING ·Phase: PHASE1

A Study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 (PF-07055480) in Subjects With Severe Hemophilia A

NCT03061201 ·Status: COMPLETED ·Phase: PHASE2

Lentiviral FVIII Gene Therapy

NCT03217032 ·Status: RECRUITING ·Phase: PHASE1

A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)

NCT03587116 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of ZS801 in Adult Hemophilia B Patients

NCT05641610 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Long-Term Safety and Efficacy of Spark-Sponsored Gene Therapies in Males With Hemophilia A

NCT03432520 ·Status: ACTIVE_NOT_RECRUITING

Data Registry in Chinese Hemophilia A and B Patients

NCT07101224 ·Status: COMPLETED

A Gene Therapy Study for Hemophilia B

NCT02484092 ·Status: COMPLETED ·Phase: PHASE2

The Efficacy and Safety of ZS801 in Chinese Hemophilia B Patients.

NCT05630651 ·Status: RECRUITING ·Phase: NA

The Efficacy and Safety of ZS802 in Chinese Hemophilia A Patients.

NCT05523128 ·Status: RECRUITING ·Phase: NA

A Study of FVIII Gene Therapy for Hemophilia A

NCT05454774 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Gene Therapy for Chinese Hemophilia A

NCT04728841 ·Status: RECRUITING ·Phase: NA

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

NCT05568719 ·Status: RECRUITING ·Phase: PHASE3

Long Term Follow-up (LTFU) of Subjects Who Received SB-318, SB-913, or SB-FIX

NCT04628871 ·Status: ACTIVE_NOT_RECRUITING

Safety and Efficacy Study of NGGT003 in Hemophilia A Patients

NCT06238908 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Comparison of Efficacy, Safety and Costs of Recombinant FVIII Products Between On-demand and Secondary Prophylaxis Groups in Haemophilia A Patients

NCT01817868 ·Status: COMPLETED

A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B

NCT03861273 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A

NCT07226206 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults

NCT04370054 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

To Evaluate the Clinical Study of GS1191-0445 Injection in the Treatment of Hemophilia A

NCT06833983 ·Status: RECRUITING ·Phase: PHASE3

Retrospective Study in Chinese Pediatric Hemophilia A Patients With rFⅧ Contained Regular Prophylaxis

NCT02263066 ·Status: COMPLETED

A Trial to Compare Prophylaxis Therapy to On-demand Therapy With a New Full Length Recombinant FVIII in Patients With Severe Hemophilia A

NCT01233258 ·Status: COMPLETED ·Phase: PHASE3

Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia B

NCT03307980 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Liver Biopsy Following Gene Therapy For Hemophilia

NCT05932914 ·Status: NOT_YET_RECRUITING